FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34848711000001101: Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105601201000001116 Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105601301000001113 Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Is a Generic Symtuza 800mg/150mg/200mg/10mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Has AMP Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Has specific active ingredient Emtricitabine true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Has specific active ingredient Darunavir ethanolate true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Has specific active ingredient Cobicistat true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Has specific active ingredient Tenofovir alafenamide fumarate false Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Darunavir true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tenofovir alafenamide true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd) 30 tablet Has specific active ingredient Tenofovir alafenamide fumarate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start